Putting Patients and Sites at the Center of Your Clinical Trial

Leonard Chuck, MD, PhD, Co-Medical Director, Internist, Diablo Clinical Research

Dr. Chuck has been with Diablo Clinical Research since 2006 as a sub-investigator and in 2007 he became co-medical director of our facility and principal investigator for many of our studies. Prior to joining Diablo Clinical Research, Dr. Chuck was in community practice for twenty years as an internist. Prior to his community work, Dr. Chuck spent ten years as a clinical/laboratory researcher at several major academic institutions, including UCLA, Cedars of Lebanon, The Cardiovascular Research Institute at UCSF, The University of Antwerp in Belgium and The University of Calgary.

Jonathan Andrus, Chief Data and Privacy Officer, Clinical Ink

As Chief Operating Officer, Jonathan Andrus leads Clinical Ink’s global data management and quality & compliance teams to help drug sponsors better leverage eSource data. With 20+ years of experience, Mr. Andrus brings extensive expertise developing eClinical services that integrate data and technology to help life science companies optimize study execution.

Mr. Andrus joined Clinical Ink from Bioclinica where he led the eClinical Solutions Group to develop their current service offerings, including data management, quality management, implementation services and IWRS. While at Bioclinica, Mr. Andrus built relationships and forged strategic partnerships with sponsors, CROs, regulatory bodies, technology developers and clinical research professionals. Prior to BioClinica, Mr. Andrus worked in pharmaceutical consulting and with CROs focused on quality, data management and validation.

An active thought leader, blogger and presenter, Jonathan served as chair of the Society for Clinical Data Management (SCDM) in 2008 and 2014 and currently serves as the society’s Treasurer. He is also an active member of DIA, ASQ, ACRO and CDISC. He earned his bachelor’s and master’s degrees from Temple University’s College of Liberal Arts and Graduate School of Pharmacy and is a Certified Quality Auditor (CQA) and Certified Clinical Data Manager (CCDM^®).

Doug Pierce, President & Co-Founder, Clinical Ink

Doug Pierce co-founded Clinical Ink in 2007 to revolutionize clinical trials by eliminating the complexities and costs associated with paper-based data capture processes. In his role as President and Co-Founder, Mr. Pierce brings 20+ years of experience in digital forms technology and mobile data capture to lead the strategic direction, development and evolution of Clinical Ink’s eSource Suite.

Prior to Clinical Ink, Mr. Pierce co-founded Piermed, Inc., a medical documentation solutions company specializing in data capture for primary care settings. Offering an alternative to the inefficient data capture methods traditionally used by physicians, Mr. Pierce developed a series of electronic forms to effectively streamline medical data capture and retrieval. Under Mr. Pierce’s leadership, Piermed, Inc. grew from a small regional start-up into an established corporation with customers in 48 states.

A pioneer of eSource technology for the life sciences industry, Doug is noted for giving the first eSource presentation to the U.S. Food and Drug Administration in 2008. He earned a master’s degree and bachelor’s degree in philosophy from the University of Montana.